CoChat

Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis

Chwalisz, Kristof, Perez, Maria Claudia, DeManno, Deborah, Winkel, Craig, Schubert, Gerd, Elger, Walter · 2005 · Endocrine Reviews

The DOI matches its Crossref record; 122 of the 127 references it cites were found in a registry or an index.

Abstract

Selective progesterone receptor modulators (SPRMs) represent a new class of progesterone receptor ligands. SPRMs exert clinically relevant tissue-selective progesterone agonist, antagonist, or mixed agonist/antagonist effects on various progesterone target tissues in vivo. Asoprisnil (J867) is the first SPRM to reach an advanced stage of clinical development for the treatment of symptomatic uterine fibroids and endometriosis. Asoprisnil belongs to the class of 11beta-benzaldoxime-substituted estratrienes that exhibit partial progesterone agonist/antagonist effects with high progesterone receptor specificity in animals and humans. Asoprisnil has no antiglucocorticoid activity in humans at therapeutic doses. It exhibits endometrial antiproliferative effects on the endometrium and breast in primates. Unlike progesterone antagonists, asoprisnil does not induce labor in relevant models of pregnancy and parturition. It induces amenorrhea primarily by targeting the endometrium. In human subjects with uterine fibroids, asoprisnil suppressed both the duration and intensity of uterine bleeding in a dose-dependent manner and reduced tumor volume in the absence of estrogen deprivation. In subjects with endometriosis, asoprisnil was effective in reducing nonmenstrual pain and dysmenorrhea. Asoprisnil may, therefore, provide a novel, tissue-selective approach to control endometriosis-related pain. SPRMs have the potential to become a novel treatment of uterine fibroids and endometriosis.

Overview

Integrity signals

Registry

Crossref · 10.1210/er.2005-0001

Cites

122 of 122 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 122 references

Research works printed but not linked: 4

  1. Giangrande, Recent Prog Horm Res, 54, 291
  2. Brenner, 2005, Asoprisnil suppresses endometrial proliferation in cynomolgus macaques., J Soc Gynecol Invest, 12, 208A
  3. Bilyeu, 2002, Interspecies comparison: In vitro metabolism of J867 by hepatocytes and microsomes from male and female human, and various animal species., Drug Metab Rev, 34, 46
  4. Morris, 2002, Interspecies comparison of the metabolism of J867 following intravenous or oral administration to male and female bile duct-cannulated rats and mice., Drug Metab Rev, 34, 73

Cited by

See all 315

Metadata

Authors
Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W.
Affiliations
  • TAP Pharmaceutical Products, Inc. (K.C., M.C.P., D.D.), Lake Forest, Illinois 60045;
  • Georgetown University (US)
  • Jenapharm GmbH & Co. (G.S.), 07745 Jena, Germany;
  • EnTec GmbH (W.E.), 07745 Jena, Germany
Venue
Endocrine Reviews
Published
2005-04-27
Volume
26
Issue
3
Pages
423-438
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W1986914259
Cited by
310
References
127
Citations by year
2026: 4 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 16 · 2018: 18 · 2017: 23 · 2016: 11 · 2015: 21 · 2014: 19 · 2013: 21 · 2012: 21
FWCI
5.03
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
selective progesterone receptor modulators, asoprisnil, uterine fibroids, leiomyoma, endometriosis, amenorrhea, dysmenorrhea, drug development
MeSH terms
Animals, Clinical Trials as Topic, Endometriosis, Estrenes, Female, Humans, Leiomyoma, Oximes, Oxytocics, Progesterone, Receptors, Progesterone, Uterine Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis. https://app.cochat.ai/papers/10.1210/er.2005-0001
The paper
Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W. (2005). Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis. Endocrine Reviews. https://doi.org/10.1210/er.2005-0001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.